Trial intelligence / Profile preview

Sirolimus Withdrawal for Liver Transplant Tolerance

NCT02062944Phase 2Completed

Sponsor
Northwestern University
Start
Mar 2013
Primary completion
Jul 2020
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of sirolimus in Liver transplant rejection, sponsored by Northwestern University. Started Mar 2013; status: completed.

02

Drugs

sirolimus
03

Conditions

Liver transplant rejection

Beyond the preview

Go deeper on NCT02062944.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02062944.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call